1 study on Romiplostim curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This research provides compelling preclinical evidence that thrombopoietin receptor agonists could offer a targeted and effective therapeutic strategy for MYH9-RD, a rare disease with significant unmet medical needs. …